comparemela.com

Latest Breaking News On - Mood therapeutics - Page 1 : comparemela.com

Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program

Roche announced it will acquire Good Therapeutics, a Seattle-based preclinical biotech, for $250 million. The deal makes Roche responsible for developing and commercializing Good's lead program, which seeks to make oncology drugs that target PD-1 proteins more effective, such as Keytruda or Opdivo.

Alla Affärsvärldens analyser vecka 29

Alla Affärsvärldens analyser vecka 29
affarsvarlden.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from affarsvarlden.se Daily Mail and Mail on Sunday newspapers.

IPO-aktuella Modus Therapeutics utvecklar potentiellt banbrytande behandling för sepsis och septisk chock

IPO-aktuella Modus Therapeutics utvecklar potentiellt banbrytande behandling för sepsis och septisk chock
di.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from di.se Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.